Search alternatives:
teer decrease » greater decrease (Expand Search)
mean decrease » a decrease (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
Showing 161 - 180 results of 11,681 for search '(( 50 ms decrease ) OR ( 5 ((teer decrease) OR (((nn decrease) OR (mean decrease)))) ))', query time: 0.44s Refine Results
  1. 161
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 162
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 163
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 164
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 165
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 166
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 167
    GC-MS chromatogram of garlic essential oil.

    GC-MS chromatogram of garlic essential oil. by Huda H. Elbehery (22492996)

    Published 2025
    Save to List
    Saved in:
  8. 168
    Means ratings for FFM traits at each age interval for the self and others with post hoc analyses for mean differences.

    Means ratings for FFM traits at each age interval for the self and others with post hoc analyses for mean differences. by Joanna Gutral (12101779)

    Published 2022
    Save to List
    Saved in:
  9. 169
    Distribution of mean seasonal rainfall in the study area.

    Distribution of mean seasonal rainfall in the study area. by Menbere Sahilu (18195856)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 170
    Distribution of mean monthly rainfall in the study area.

    Distribution of mean monthly rainfall in the study area. by Menbere Sahilu (18195856)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 171
    Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone.

    Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. by Brenda Lyn A. Gavina (15285185)

    Published 2023
    Save to List
    Saved in:
  12. 172
    Descriptive statistics of data presented in Tables 2–5.

    Descriptive statistics of data presented in Tables 2–5. by Héctor Raúl Olivares-Sánchez (13014866)

    Published 2022
    Save to List
    Saved in:
  13. 173
    RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression.

    RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression. by Xiaojuan Li (351842)

    Published 2023
    Save to List
    Saved in:
  14. 174
    Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR.

    Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR. by Jordan A. Gunning (18143970)

    Published 2024
    Save to List
    Saved in:
  15. 175
    Fig 5 -

    Fig 5 - by Harshita Sharma (4836180)

    Published 2023
    Save to List
    Saved in:
  16. 176
    Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study.

    Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. by Angelina R. Sutin (9216456)

    Published 2022
    Save to List
    Saved in:
  17. 177
    Mean change in pain severity and interference from baseline to 8 weeks.

    Mean change in pain severity and interference from baseline to 8 weeks. by Judith I. Tsui (5983160)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 178
    Effects of FE and RUD wrist postures on the mean carpal tunnel depth within each quartile.

    Effects of FE and RUD wrist postures on the mean carpal tunnel depth within each quartile. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 179
    Effects of FE and RUD wrist postures on the mean carpal tunnel width within each quartile.

    Effects of FE and RUD wrist postures on the mean carpal tunnel width within each quartile. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 180
    Effects of FE and RUD wrist postures on the mean cross-sectional area within each quartile.

    Effects of FE and RUD wrist postures on the mean cross-sectional area within each quartile. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: